STAT-6 inhibitors (Tularik/Roche Bioscience)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSTAT-6 inhibitors (Tularik/Roche Bioscience)
Drug Alias NameSTAT-6 modulators (Tularik/Roche Bioscience)interleukin-1 receptor-associated protein kinase inhibitors (Tularik)IKK-1 modulators (Tularik)IKKalpha modulators (Tularik)IL-1 pathway modulators (Tularik/Roche Bioscience) +[11] 
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionSignal transducer and activator of transcription 6 inhibitors
TargetsSignal transducer and activator of transcription 6
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTularik Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTularik IncRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A